BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 30
• 31

• Business

  ONWARD Schedules Webcast to Provide Third Quarter 2022 Business Update and Announces Participation at Upcoming Conferences

  ONWARD Medical N.V., the medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injury, announced that it will host a webcast to discuss its Q3 business highlights.

  October 27, 2022

   · 

  5 min read
• Business

  BioInvent International AB: Interim report January-September 2022

  BioInvent further strengthened its financial position in the third quarter through a directed share issue.

  October 27, 2022

   · 

  3 min read
• Business

  Takeda Delivers Strong FY2022 H1 Results and Raises Full-Year Forecast

  Takeda announced financial results for the first half of fiscal year 2022, upgrading reported and core forecasts and free cash flow outlook for the fiscal year and reconfirming Management Guidance for core growth at constant exchange rate.

  October 27, 2022

   · 

  16 min read
• Business

  Sobi publishes Q3 2022 report

  Swedish Orphan Biovitrum AB announced its report for the third quarter of 2022.

  October 27, 2022

   · 

  3 min read
• Drug Development

  GSK, MorphoSys’ Licensing Partner, Provides Update on ContRAst Phase III Program for Otilimab in Moderate to Severe Rheumatoid Arthritis

  MorphoSys AG announced that its licensing partner, GSK plc, provided an update on the ContRAst phase III program for otilimab as a potential treatment of moderate to severe rheumatoid arthritis.

  October 27, 2022

   · 

  3 min read
• Gerresheimer and Merck KGaA, Darmstadt, Germany, Transform Primary Packaging into Digital Twins

  Gerresheimer AG and Merck KGaA, Darmstadt, Germany jointly developed a digital twin solution to further ensure traceability and trust in crucial steps along the pharmaceutical supply chain.

  October 27, 2022

   · 

  2 min read
• Biotech Bay

  Boehringer Ingelheim Extends the Use of Medidata Rave for Electronic Data Capture in Clinical Trials

  Medidata, a Dassault Systèmes company, and Boehringer Ingelheim announced a five-year renewal of their collaboration in the wider area of electronic data capture.

  October 27, 2022

   · 

  4 min read
• Business

  Immunic, Inc. to Announce Financial Results for the Third Quarter Ended September 30, 2022, and Provide Corporate Update

  Immunic, Inc. announced that the company will release its financial results for the third quarter ended September 30, 2022, including a corporate update, on Thursday, November 3, 2022, before the opening of the U.S. financial markets.

  October 27, 2022

   · 

  4 min read
• Business

  Indigo Diabetes Incorporates Fully Owned Subsidiary in the US and Appoints Peter J. Devlin as President, Indigo Medical US Inc.

  Indigo Diabetes N.V. announces its expansion into the US via the incorporation of a fully owned subsidiary, Indigo Medical US Inc., and the appointment of Peter J. Devlin as President of the newly formed subsidiary, effective from 14 October 2022.

  October 27, 2022

   · 

  4 min read
• Business

  Arvinas Announces Winner of the 2022 Arvinas Early Career Researcher Award

  Arvinas, Inc. announced Katherine Donovan, Ph.D. of the Dana-Farber Cancer Institute/Harvard Medical School as the winner of the 2022 Arvinas Early Career Research Award last night at the 5th Annual Targeted Protein Degradation Summit in Boston.

  October 27, 2022

   · 

  3 min read